End-of-day quote
Korea S.E.
18:00:00 2024-06-27 EDT
|
5-day change
|
1st Jan Change
|
2,790
KRW
|
-0.89%
|
|
-3.63%
|
-39.61%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
382,950
|
205,350
|
119,140
|
97,020
|
Enterprise Value (EV)
1 |
401,192
|
204,451
|
120,171
|
95,761
|
P/E ratio
|
62.2
x
|
-7.8
x
|
-14.6
x
|
-19.2
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
4.78
x
|
6.15
x
|
3
x
|
9.26
x
|
EV / Revenue
|
5.01
x
|
6.12
x
|
3.02
x
|
9.14
x
|
EV / EBITDA
|
17.8
x
|
-34.8
x
|
-29.9
x
|
-8.92
x
|
EV / FCF
|
-5.63
x
|
160
x
|
592
x
|
-9.2
x
|
FCF Yield
|
-17.8%
|
0.63%
|
0.17%
|
-10.9%
|
Price to Book
|
6.36
x
|
7.29
x
|
10.1
x
|
5.74
x
|
Nbr of stocks (in thousands)
|
17,250
|
18,500
|
18,500
|
21,000
|
Reference price
2 |
22,200
|
11,100
|
6,440
|
4,620
|
Announcement Date
|
21-03-01
|
22-03-01
|
23-03-01
|
24-02-29
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
31,438
|
49,654
|
80,147
|
33,416
|
39,769
|
10,477
|
EBITDA
1 |
598.8
|
-5,940
|
22,558
|
-5,877
|
-4,020
|
-10,730
|
EBIT
1 |
-319.5
|
-7,861
|
16,155
|
-13,053
|
-6,647
|
-11,689
|
Operating Margin
|
-1.02%
|
-15.83%
|
20.16%
|
-39.06%
|
-16.71%
|
-111.57%
|
Earnings before Tax (EBT)
1 |
15.73
|
-9,876
|
13,768
|
-52,010
|
-16,358
|
-9,610
|
Net income
1 |
-2,377
|
-9,271
|
12,457
|
-52,010
|
-16,358
|
-9,140
|
Net margin
|
-7.56%
|
-18.67%
|
15.54%
|
-155.64%
|
-41.13%
|
-87.24%
|
EPS
2 |
-90.00
|
-305.0
|
357.0
|
-1,422
|
-442.1
|
-240.5
|
Free Cash Flow
1 |
-10,583
|
22,088
|
-71,234
|
1,281
|
203.1
|
-10,407
|
FCF margin
|
-33.66%
|
44.48%
|
-88.88%
|
3.83%
|
0.51%
|
-99.33%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
19-03-01
|
20-02-29
|
21-03-01
|
22-03-01
|
23-03-01
|
24-02-29
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
15,192
|
18,242
|
-
|
1,031
|
-
|
Net Cash position
1 |
3,627
|
-
|
-
|
899
|
-
|
1,259
|
Leverage (Debt/EBITDA)
|
-
|
-2.558
x
|
0.8087
x
|
-
|
-0.2566
x
|
-
|
Free Cash Flow
1 |
-10,583
|
22,088
|
-71,234
|
1,281
|
203
|
-10,407
|
ROE (net income / shareholders' equity)
|
-17.3%
|
-41.2%
|
31.5%
|
-118%
|
-81.9%
|
-63.7%
|
ROA (Net income/ Total Assets)
|
-0.76%
|
-7.3%
|
10.2%
|
-11.3%
|
-11.3%
|
-26%
|
Assets
1 |
311,521
|
126,985
|
121,573
|
460,314
|
144,704
|
35,195
|
Book Value Per Share
2 |
986.0
|
621.0
|
3,488
|
1,522
|
638.0
|
805.0
|
Cash Flow per Share
2 |
251.0
|
332.0
|
566.0
|
672.0
|
532.0
|
207.0
|
Capex
1 |
15,748
|
8,607
|
45,460
|
2,288
|
720
|
859
|
Capex / Sales
|
50.09%
|
17.33%
|
56.72%
|
6.85%
|
1.81%
|
8.2%
|
Announcement Date
|
19-03-01
|
20-02-29
|
21-03-01
|
22-03-01
|
23-03-01
|
24-02-29
|
|
1st Jan change
|
Capi.
|
---|
| -39.61% | 42.52M | | +19.99% | 67.97B | | -6.03% | 45.92B | | +22.27% | 43.74B | | +33.20% | 28.16B | | +8.15% | 19.17B | | +14.71% | 17.12B | | -13.18% | 14.73B | | -27.99% | 14.52B | | -32.33% | 11.64B |
Other Specialty Chemicals
|